BIOMAT Database Logo BIOMAT Database Logo

Occurrence of multiple myeloma in both donor and recipient after bone marrow transplantation. 2002

Arun Kumar, and Michael J Styler, and David L Topolsky, and Pamela A Crilley, and Thomas M Przybysz, and Douglas E Gladstone
College of Medicine, Drexel University, 245 North 15th Street, Philadelphia, PA 19102, USA.

The transplantation of malignant cells during allogeneic transplant is a rare occurrence. 27 months after donating progenitor cells, a diagnosis of multiple myeloma was made in a 6/6 HLA-phenotypically matched unrelated donor. The 42-year-old recipient transplanted for chronic phase chronic myeloid leukemia developed IgA myeloma 40 months after transplantation. Serum electrophoresis and bone marrow investigations established the diagnosis of IgA K multiple myeloma in both. This case illustrates the natural history and biology of multiple myeloma.

UI MeSH Term Description Entries
D008297 Male Males
D009101 Multiple Myeloma A malignancy of mature PLASMA CELLS engaging in monoclonal immunoglobulin production. It is characterized by hyperglobulinemia, excess Bence-Jones proteins (free monoclonal IMMUNOGLOBULIN LIGHT CHAINS) in the urine, skeletal destruction, bone pain, and fractures. Other features include ANEMIA; HYPERCALCEMIA; and RENAL INSUFFICIENCY. Myeloma, Plasma-Cell,Kahler Disease,Myeloma, Multiple,Myeloma-Multiple,Myelomatosis,Plasma Cell Myeloma,Cell Myeloma, Plasma,Cell Myelomas, Plasma,Disease, Kahler,Multiple Myelomas,Myeloma Multiple,Myeloma, Plasma Cell,Myeloma-Multiples,Myelomas, Multiple,Myelomas, Plasma Cell,Myelomas, Plasma-Cell,Myelomatoses,Plasma Cell Myelomas,Plasma-Cell Myeloma,Plasma-Cell Myelomas
D006801 Humans Members of the species Homo sapiens. Homo sapiens,Man (Taxonomy),Human,Man, Modern,Modern Man
D000328 Adult A person having attained full growth or maturity. Adults are of 19 through 44 years of age. For a person between 19 and 24 years of age, YOUNG ADULT is available. Adults
D014019 Tissue Donors Individuals supplying living tissue, organs, cells, blood or blood components for transfer or transplantation to histocompatible recipients. Organ Donors,Donors,Ovum Donors,Semen Donors,Transplant Donors,Donor,Donor, Organ,Donor, Ovum,Donor, Semen,Donor, Tissue,Donor, Transplant,Donors, Organ,Donors, Ovum,Donors, Semen,Donors, Tissue,Donors, Transplant,Organ Donor,Ovum Donor,Semen Donor,Tissue Donor,Transplant Donor
D015464 Leukemia, Myelogenous, Chronic, BCR-ABL Positive Clonal hematopoetic disorder caused by an acquired genetic defect in PLURIPOTENT STEM CELLS. It starts in MYELOID CELLS of the bone marrow, invades the blood and then other organs. The condition progresses from a stable, more indolent, chronic phase (LEUKEMIA, MYELOID, CHRONIC PHASE) lasting up to 7 years, to an advanced phase composed of an accelerated phase (LEUKEMIA, MYELOID, ACCELERATED PHASE) and BLAST CRISIS. Granulocytic Leukemia, Chronic,Leukemia, Granulocytic, Chronic,Leukemia, Myelocytic, Chronic,Leukemia, Myelogenous, Chronic,Leukemia, Myeloid, Chronic,Myelocytic Leukemia, Chronic,Myelogenous Leukemia, Chronic,Myeloid Leukemia, Chronic,Leukemia, Chronic Myelogenous,Leukemia, Chronic Myeloid,Leukemia, Myelogenous, Ph1 Positive,Leukemia, Myelogenous, Ph1-Positive,Leukemia, Myeloid, Ph1 Positive,Leukemia, Myeloid, Ph1-Positive,Leukemia, Myeloid, Philadelphia Positive,Leukemia, Myeloid, Philadelphia-Positive,Myelogenous Leukemia, Ph1-Positive,Myeloid Leukemia, Ph1-Positive,Myeloid Leukemia, Philadelphia-Positive,Chronic Granulocytic Leukemia,Chronic Granulocytic Leukemias,Chronic Myelocytic Leukemia,Chronic Myelocytic Leukemias,Chronic Myelogenous Leukemia,Chronic Myelogenous Leukemias,Chronic Myeloid Leukemia,Chronic Myeloid Leukemias,Granulocytic Leukemias, Chronic,Leukemia, Chronic Granulocytic,Leukemia, Chronic Myelocytic,Leukemia, Ph1-Positive Myelogenous,Leukemia, Ph1-Positive Myeloid,Leukemia, Philadelphia-Positive Myeloid,Leukemias, Chronic Granulocytic,Leukemias, Chronic Myelocytic,Leukemias, Chronic Myelogenous,Leukemias, Chronic Myeloid,Leukemias, Ph1-Positive Myelogenous,Leukemias, Ph1-Positive Myeloid,Leukemias, Philadelphia-Positive Myeloid,Myelocytic Leukemias, Chronic,Myelogenous Leukemia, Ph1 Positive,Myelogenous Leukemias, Chronic,Myelogenous Leukemias, Ph1-Positive,Myeloid Leukemia, Ph1 Positive,Myeloid Leukemia, Philadelphia Positive,Myeloid Leukemias, Chronic,Myeloid Leukemias, Ph1-Positive,Myeloid Leukemias, Philadelphia-Positive,Ph1-Positive Myelogenous Leukemia,Ph1-Positive Myelogenous Leukemias,Ph1-Positive Myeloid Leukemia,Ph1-Positive Myeloid Leukemias,Philadelphia-Positive Myeloid Leukemia,Philadelphia-Positive Myeloid Leukemias
D016026 Bone Marrow Transplantation The transference of BONE MARROW from one human or animal to another for a variety of purposes including HEMATOPOIETIC STEM CELL TRANSPLANTATION or MESENCHYMAL STEM CELL TRANSPLANTATION. Bone Marrow Cell Transplantation,Grafting, Bone Marrow,Transplantation, Bone Marrow,Transplantation, Bone Marrow Cell,Bone Marrow Grafting

Related Publications

Arun Kumar, and Michael J Styler, and David L Topolsky, and Pamela A Crilley, and Thomas M Przybysz, and Douglas E Gladstone
Cyclosporin A pretreatment of both donor and recipient undergoing allogeneic bone marrow transplantation.
October 1985, Scandinavian journal of haematology,
Arun Kumar, and Michael J Styler, and David L Topolsky, and Pamela A Crilley, and Thomas M Przybysz, and Douglas E Gladstone
Development of hyperthyroidism in donor and recipient after allogeneic bone marrow transplantation.
October 1992, Bone marrow transplantation,
Arun Kumar, and Michael J Styler, and David L Topolsky, and Pamela A Crilley, and Thomas M Przybysz, and Douglas E Gladstone
Donor leukocyte infusions are effective in relapsed multiple myeloma after allogeneic bone marrow transplantation.
November 1997, Blood,
Arun Kumar, and Michael J Styler, and David L Topolsky, and Pamela A Crilley, and Thomas M Przybysz, and Douglas E Gladstone
Occurrence rate of the HLA-identical pair donor-recipient for bone marrow transplantation.
January 1990, Neoplasma,
Arun Kumar, and Michael J Styler, and David L Topolsky, and Pamela A Crilley, and Thomas M Przybysz, and Douglas E Gladstone
Hematopoietic donor chimerism and graft-versus-myeloma effect in relapse of multiple myeloma after allogeneic bone marrow transplantation.
August 1999, Annals of hematology,
Arun Kumar, and Michael J Styler, and David L Topolsky, and Pamela A Crilley, and Thomas M Przybysz, and Douglas E Gladstone
Detection of identical T-cell clonotype expansions in both the donor and recipient after allogeneic bone marrow transplantation.
July 1999, British journal of haematology,
Arun Kumar, and Michael J Styler, and David L Topolsky, and Pamela A Crilley, and Thomas M Przybysz, and Douglas E Gladstone
Bone marrow transplantation in multiple myeloma.
March 1999, Current opinion in oncology,
Arun Kumar, and Michael J Styler, and David L Topolsky, and Pamela A Crilley, and Thomas M Przybysz, and Douglas E Gladstone
Bone marrow transplantation in multiple myeloma.
February 1986, Scandinavian journal of haematology,
Arun Kumar, and Michael J Styler, and David L Topolsky, and Pamela A Crilley, and Thomas M Przybysz, and Douglas E Gladstone
Bone marrow transplantation in multiple myeloma.
February 1991, Bone marrow transplantation,
Arun Kumar, and Michael J Styler, and David L Topolsky, and Pamela A Crilley, and Thomas M Przybysz, and Douglas E Gladstone
Bone marrow transplantation in multiple myeloma.
July 1993, Leukemia,
Copied contents to your clipboard!